Inventor · disambiguated record
Chao-Yie Yang
Also filed as: YANG CHAO · YANG CHAO-YIE
23 granted patents·12 pending applications·112 citations·filing 2005–2025
93Inventor score
Files withUNIV MICHIGAN REGENTS14UNIV HONG KONG SCIENCE & TECH4ASCENTAGE PHARMA SUZHOU CO LTD3UNIV MICHIGAN3CHINA PETROLEUM & CHEM CORP2
Top patents by PatentIndex Score
35 records- 0194US8691184B2Bcl-2/Bcl-xL inhibitors and therapeutic methods using the sameWANG SHAOMENG·Filed 2012·Granted Apr 8, 2014·42 cites·15 claims
- 0293US7932382B2Conformationally constrained Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2005·Granted Apr 26, 2011·17 cites·4 claims
- 0390US7674787B2Conformationally constrained Smac mimetics and the uses thereofUNIV MICHIGAN·Filed 2005·Granted Mar 9, 2010·16 cites·4 claims
- 0489US9675697B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2014·Granted Jun 13, 2017·16 cites·21 claims
- 0585US10391175B2BET bromodomain inhibitors and therapeutic methods using the sameUNIV MICHIGAN REGENTS·Filed 2017·Granted Aug 27, 2019·6 cites·18 claims
- 0679US11691989B2Macrocyclic indoles as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jul 4, 2023·3 cites·41 claims
- 0779US10759808B2Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2017·Granted Sep 1, 2020·2 cites·20 claims
- 0877US11168082B2Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitorsUNIV MICHIGAN REGENTS·Filed 2018·Granted Nov 9, 2021·2 cites·20 claims
- 0977US9562047B2Pyrazolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2013·Granted Feb 7, 2017·3 cites·9 claims
- 1077US2025034162A1Imidazopyrimidines as eed inhibitors and the use thereofUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 1174US9290499B2Pyrazolopyrimidine compounds for the treatment of cancerWANG XIAODONG·Filed 2011·Granted Mar 22, 2016·3 cites·22 claims
- 1268US9783539B2Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitorsJIANGSU ASCENTAGE BIOMED DEV INC·Filed 2014·Granted Oct 10, 2017·2 cites·20 claims
- 1367US11891458B2Starch-containing microsphere and preparation method and use thereofCHINA PETROLEUM & CHEM CORP·Filed 2022·Granted Feb 6, 2024·0 cites·13 claims
- 1465US2024141356A1Driving Axon Regeneration by Activating STAT1 Signaling and cGAS-STING PathwayUNIV HONG KONG SCIENCE & TECH·Filed 2023·Application pending·0 cites
- 1564US12145944B2Imidazopyrimidines as EED inhibitors and the use thereofUNIV MICHIGAN REGENTS·Filed 2020·Granted Nov 19, 2024·0 cites·14 claims
- 1664US2024374570A1Driving axon regeneration by nrf2 overexpression and edaravone applicationUNIV HONG KONG SCIENCE & TECH·Filed 2024·Application pending·0 cites
- 1762US12016933B2Method for stimulating axonal regenerationUNIV HONG KONG SCIENCE & TECH·Filed 2020·Granted Jun 25, 2024·0 cites·5 claims
- 1857US2021002289A1Monofunctional intermediates for ligand-dependent target protein degradationUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 1955US9744172B2Pyrazolopyrimidine compounds for the treatment of cancerUNIV NORTH CAROLINA CHAPEL HILL·Filed 2016·Granted Aug 29, 2017·0 cites·22 claims
- 2055US2021032373A1Starch-containing microsphere and preparation method and use thereofCHINA PETROLEUM & CHEM CORP·Filed 2018·Application pending·0 cites
- 2150US2022081435A1Androgen receptor protein degradersUNIV MICHIGAN REGENTS·Filed 2019·Application pending·0 cites
- 2249US2025332273A1Spider silk protein-based hydrogel enables injectable and sustained delivery of protein therapeutics for neuroprotection and axon regenerationUNIV HONG KONG SCIENCE & TECH·Filed 2025·Application pending·0 cites
- 2347US11548899B2Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Jan 10, 2023·0 cites·16 claims
- 2447US2023083015A1Small molecule degraders of stat3UNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 2546US2022380368A1Spirocyclic androgen receptor protein degradersUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 2645US12319703B2Macrocyclic fused pyrazoles as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jun 3, 2025·0 cites·20 claims
- 2743US11498928B2Macrocyclic spiroethers as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Nov 15, 2022·0 cites·47 claims
- 2843US10889497B2Sheet-shaped nitrogen-phosphorus co-doped porous carbon material and method for preparation thereof and use thereofUNIV WENZHOU·Filed 2017·Granted Jan 12, 2021·0 cites·9 claims
- 2943US2006247305A1Chromen-4-one inhibitors of anti-apoptotic Bcl-2 family members and the uses thereofUNIV MICHIGAN·Filed 2006·Application pending·0 cites
- 3042US11028111B2Compound for treating metabolic diseases and preparation method and use thereofXI AN BIOCARE PHARMA LTD·Filed 2018·Granted Jun 8, 2021·0 cites·16 claims
- 3142US2021087188A15,6-dihydro-1 1h-indolo{2,3-b}quinolin- 11-one compounds as alk inhibitorsUNIV MICHIGAN REGENTS·Filed 2019·Application pending·0 cites
- 3241US2010093645A1SMAC Peptidomimetics and the Uses ThereofWANG SHAOMENG·Filed 2005·Application pending·0 cites
- 3339US10781208B25,6-dihydro-11H-indolo[2,3-B]quinolin-11-ones as alk inhibitorsUNIV MICHIGAN REGENTS·Filed 2017·Granted Sep 22, 2020·0 cites·15 claims
- 3438US10633386B2BET protein degradersUNIV MICHIGAN REGENTS·Filed 2017·Granted Apr 28, 2020·0 cites·19 claims
- 3533US11364390B2Apparatus for treating pathological cellsTOFANI SANTI·Filed 2018·Granted Jun 21, 2022·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Chao-Yie Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →